Adam Spitz, an endocrinologist, and Georgina Farrow, a clinical pharmacist, to unpack the science, success stories, safety concerns, and future outlook for GLP-1 medications like Ozempic and Mounjaro for people with T1D
Once that stability is achieved, other metabolic peptides can be introduced to rebuild the foundation. By supporting lean muscle mass, boosting metabolic rate, and enhancing mitochondrial health, these peptides help ensure that the weight loss is primarily from fat and is sustainable for the long term
This decline happens naturally with age, but obesity accelerates the process significantly
The clinical numbers tell the story clearly
Studies examine GLP-1s potential role in: Results may vary